Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 4 studies | 22% ± 2% | |
GABAergic neuron | 3 studies | 34% ± 7% | |
glutamatergic neuron | 3 studies | 43% ± 7% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 30% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 399.40 | 2637 / 2642 | 100% | 4.04 | 702 / 705 |
skin | 99% | 364.56 | 1796 / 1809 | 99% | 17.72 | 469 / 472 |
esophagus | 98% | 214.08 | 1422 / 1445 | 99% | 6.58 | 181 / 183 |
uterus | 99% | 175.26 | 168 / 170 | 96% | 5.40 | 442 / 459 |
breast | 100% | 177.27 | 457 / 459 | 94% | 3.20 | 1050 / 1118 |
intestine | 99% | 176.17 | 961 / 966 | 93% | 4.62 | 492 / 527 |
ovary | 99% | 193.31 | 179 / 180 | 91% | 2.43 | 392 / 430 |
lung | 93% | 134.10 | 540 / 578 | 96% | 4.32 | 1108 / 1155 |
thymus | 98% | 140.72 | 643 / 653 | 87% | 1.89 | 527 / 605 |
bladder | 100% | 152.57 | 21 / 21 | 83% | 3.83 | 419 / 504 |
prostate | 99% | 173.93 | 243 / 245 | 74% | 1.62 | 369 / 502 |
liver | 100% | 135.39 | 225 / 226 | 71% | 1.63 | 290 / 406 |
adrenal gland | 93% | 94.42 | 239 / 258 | 73% | 2.10 | 168 / 230 |
pancreas | 83% | 74.15 | 273 / 328 | 74% | 1.60 | 132 / 178 |
stomach | 65% | 66.27 | 235 / 359 | 92% | 4.24 | 262 / 286 |
kidney | 88% | 85.79 | 78 / 89 | 68% | 1.32 | 612 / 901 |
lymph node | 0% | 0 | 0 / 0 | 100% | 7.48 | 29 / 29 |
spleen | 100% | 173.41 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 5.61 | 45 / 45 |
adipose | 99% | 170.77 | 1195 / 1204 | 0% | 0 | 0 / 0 |
muscle | 98% | 133.60 | 784 / 803 | 0% | 0 | 0 / 0 |
heart | 91% | 122.72 | 784 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 81% | 4.09 | 65 / 80 |
blood vessel | 61% | 57.73 | 819 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 26% | 292.32 | 245 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0051607 | Biological process | defense response to virus |
GO_0006359 | Biological process | regulation of transcription by RNA polymerase III |
GO_0032728 | Biological process | positive regulation of interferon-beta production |
GO_0045089 | Biological process | positive regulation of innate immune response |
GO_0008283 | Biological process | cell population proliferation |
GO_0006383 | Biological process | transcription by RNA polymerase III |
GO_0045087 | Biological process | innate immune response |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0016604 | Cellular component | nuclear body |
GO_0005666 | Cellular component | RNA polymerase III complex |
GO_0005634 | Cellular component | nucleus |
GO_0003682 | Molecular function | chromatin binding |
GO_0005515 | Molecular function | protein binding |
GO_0003899 | Molecular function | DNA-directed 5'-3' RNA polymerase activity |
Gene name | POLR3G |
Protein name | Alternative protein POLR3G RNA polymerase III subunit G DNA-directed RNA polymerase III subunit RPC7 (RNA polymerase III subunit C7) (DNA-directed RNA polymerase III subunit G) (RNA polymerase III 32 kDa apha subunit) (RPC32-alpha) (RNA polymerase III 32 kDa subunit) (RPC32) |
Synonyms | |
Description | FUNCTION: DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates . Specific peripheric component of RNA polymerase III (Pol III) which synthesizes small non-coding RNAs including 5S rRNA, snRNAs, tRNAs and miRNAs from at least 500 distinct genomic loci . Acts as a long tether that bridges POLR3C/RPC3-POLR3F/RPC6-POLR3G/RPC7 heterotrimer and the mobile stalk of Pol III, coordinating the dynamics of Pol III stalk and clamp modules during the transition from apo to elongation state. Pol III exists as two alternative complexes defined by the mutually exclusive incorporation of subunit POLR3G/RPC7alpha or POLR3GL/RPC7beta. POLR3G/RPC7alpha modulates Pol III transcriptome by specifically enhancing the transcription of snaR-A non-coding RNAs. At resting state, occupies the active site of apo Pol III and keeps Pol III in an autoinhibitory mode, preventing non-specific transcription . Pol III plays a key role in sensing and limiting infection by intracellular bacteria and DNA viruses. Acts as a nuclear and cytosolic DNA sensor involved in innate immune response. Can sense non-self dsDNA that serves as template for transcription into dsRNA. The non-self RNA polymerase III transcripts, such as Epstein-Barr virus-encoded RNAs (EBERs), induce type I interferon and NF-kappa-B through the RIG-I pathway . . |
Accessions | A0A7I2R591 D6RJH6 ENST00000504930.5 ENST00000514483.5 L8E8B4 ENST00000503373.5 D6REQ0 D6R9U7 ENST00000505345.5 ENST00000399107.6 ENST00000512239.1 ENST00000651687.1 D6RIT0 O15318 |